1. Ayodele OE, Alebiosu CO, Salako BL: Diabetic nephropathy —a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 2004, 96:1445–1454.
2. Parving HH, Mauer M, Ritz E: Diabetic nephropathy. In Brenner & Rector’s The Kidney, edn 7. Edited by Brenner BM. Philadelphia: WB Saunders; 2004:1777–1818.
3. Moorhead JF, El Nahas M, Chan MK, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982, 1:1309–1311.
4. Krolewski AS, Warram JHG, Christlies AR: Hypercholesterolemia-A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int Suppl 1994, 45:S125-S131.
5. Ravid M, Neumann L, Lishner M: Plasma lipids and the progression of nephropathy in diabetes mellitus type 2: effect of ACE inhibitors. Kidney Int 1995, 47:907–910.